EP3328416
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.8.2016:
13.3.2024:
16750584.1
:
31.7.2036
:
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA
1.8.2016
13.3.2024
:
BioMarin Pharmaceutical Inc.:
105 Digital Drive, Novato, CA 94949, US
:
BULLENS, Sherry:
Novato, CA 94949, US
:
BUNTING, Stuart:
Novato, CA 94949, US
:
CHOU, Tianwei:
Novato, CA 94949, US
:
OKHAMAFE, Augustus, O.:
Concord, CA 94521, US
:
PRICE, Christopher, P.:
52070 Aachen, DE
:
WENDT, Daniel, J.:
Novato, CA 94949, US
:
YAP, Clarence:
Novato, CA 94949, US
:
201562199081 P:
30.7.2015:
US
:
201662320704 P:
11.4.2016:
US
:
US2016044968:
1.8.2016
:
A61K 9/00, A61K 9/19, A61K 38/17, A61K 38/22, A61K 47/12, A61K 47/20, A61K 47/26, A61P 19/08